The modified amino acid levacetylleucine delivered clinically meaningful results in children and adults with the rare disorder ataxia-telangiectasia.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/phase-3-win-modified-amino-acid-rare-ataxia-telangiectasia-2026a1000e7q?src=rss
Author :
Publish date : 2026-05-04 13:13:00
Copyright for syndicated content belongs to the linked Source.
